|
LOC389333 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.833900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.229400E-04 |
| Normal-vs-Stage2 |
1.519570E-03 |
| Normal-vs-Stage3 |
7.100300E-02 |
| Normal-vs-Stage4 |
4.792000E-02 |
| Stage1-vs-Stage2 |
1.271380E-01 |
| Stage1-vs-Stage3 |
1.626820E-01 |
| Stage1-vs-Stage4 |
8.975800E-01 |
| Stage2-vs-Stage3 |
2.937800E-02 |
| Stage2-vs-Stage4 |
2.832200E-01 |
| Stage3-vs-Stage4 |
3.732200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.179500E-04 |
| Normal-vs-AfricanAmerican |
8.258500E-03 |
| Normal-vs-Asian |
3.779400E-01 |
| Caucasian-vs-AfricanAmerican |
1.105760E-01 |
| Caucasian-vs-Asian |
2.801200E-01 |
| AfricanAmerican-vs-Asian |
3.402200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.396200E-04 |
| Normal-vs-Female |
1.081280E-03 |
| Male-vs-Female |
3.359200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.804600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.003150E-03 |
| Normal-vs-Age(61-80Yrs) |
1.155570E-02 |
| Normal-vs-Age(81-100Yrs) |
1.240280E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.190800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.378600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.603600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.303400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.074800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.747000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.67314999999224E-05 |
| Classical-VS-Follicular |
7.006200E-01 |
| Classical-VS-Other |
1.258800E-01 |
| Classical-VS-Normal |
9.56789999999597E-05 |
| Tall-VS-Follicular |
1.369580E-04 |
| Tall-VS-Other |
9.346400E-01 |
| Tall-VS-Normal |
2.539400E-01 |
| Follicular-VS-Other |
1.324010E-01 |
| Follicular-VS-Normal |
1.541270E-03 |
| Other-VS-Normal |
5.628200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.12359999999245E-05 |
| Normal-vs-N1 |
5.442400E-01 |
| N0-vs-N1 |
1.336260E-03 |
|
|
